In the 4 decades that have elapsed since Ashbaugh and colleagues [1] first described acute
lung injury/acute respiratory distress syndrome (ALI/ARDS), tremendous strides have been …

Although the defining elements of “acute respiratory distress syndrome”(ARDS) have been
known for over a century, the syndrome was first described in 1967. Since then, despite …

Acute respiratory distress syndrome (ARDS) is a common and life-threatening cause of
respiratory failure. Despite decades of research, there are no effective pharmacologic …

Despite its high incidence and devastating outcomes, acute respiratory distress syndrome
(ARDS) has no specific treatment, with effective therapy currently limited to minimizing …

It has been known for decades that shock and sepsis can cause a syndrome of acute
respiratory failure with characteristics of non-cardiogenic pulmonary edema. Over the years …

Clinical and molecular heterogeneity are common features of human disease.
Understanding the basis for heterogeneity has led to major advances in therapy for many …

Acute respiratory distress syndrome (ARDS) is a life-threatening condition that affects
patients admitted in the Intensive Care Units (ICUs) under mechanical ventilation. ARDS is a …

Importance Acute respiratory distress syndrome (ARDS) is a life-threatening form of
respiratory failure that affects approximately 200 000 patients each year in the United States …

The acute respiratory distress syndrome (ARDS) causes 40% mortality in approximately
200,000 critically ill patients annually in the United States. ARDS is caused by protein-rich …

Improved understanding of the pathogenesis of acute lung injury (ALI)/ARDS has led to
important advances in the treatment of ALI/ARDS, particularly in the area of ventilator …